The edition · Pulmonology
Adaptive D-dimer cut-offs missed few PEs even in the 'grey zone' above 500
A meta-analysis of prospective management studies checks the patients these rules newly exclude. Also: most biologic-eligible asthma improved without a biologic, the case against widening lung screening on stage shift alone, and nasal NO to find PCD in bronchiectasis.
The edition in brief
Today's pulmonology edition closes on adaptive D-dimer thresholds for suspected pulmonary embolism. Pooling six prospective management studies of 12,194 patients, the three-month failure rate when PE was excluded without CT pulmonary angiography was 0.12% overall, and 0.50% (95% CI 0.20 to 1.11%) among patients whose D-dimer was above 500 ng/mL but below the age- or probability-adjusted cut-off. In 10,078 UK adults who first met biologic criteria for severe asthma, 70% improved to fewer than three exacerbations a year on standard care alone; a persistently frequent group had higher blood eosinophils years before eligibility. A Chest review argues that extending low-dose CT screening to people without a substantial smoking history, as in China, risks more overdiagnosis than benefit unless advanced-stage incidence falls. In 373 Chinese adults and adolescents with bronchiectasis, nasal nitric oxide screening identified primary ciliary dyskinesia in 7.4%, with sensitivity 84.8% and specificity 97.1%. The pearl covers what to check before calling asthma severe.
Seven in ten biologic-eligible asthma patients improved without a biologic
After a year of frequent exacerbations, optimise standard care and review eosinophil history before committing to a biologic.
Screening never-smokers for lung cancer: stage shift alone is not proof
Keep lung cancer screening to proven high-risk groups and discuss overdiagnosis honestly with never-smokers asking for a scan.
Nasal nitric oxide found primary ciliary dyskinesia in 7% of bronchiectasis
In bronchiectasis with early onset and chronic sinus disease, consider primary ciliary dyskinesia and refer for testing.
Before calling asthma severe, rule out the fixable
Confirm adherence, technique, exposures and comorbidities before labelling asthma severe or escalating treatment.
Age- and probability-adjusted D-dimer cut-offs held up in prospective use
Use an age-adjusted or probability-adjusted D-dimer threshold to exclude PE in non-pregnant adults without high clinical probability.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free